LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...
Related Questions
What is the expected timeline and potential financial liability of the securities class action lawsuit for Capricor?
How might this litigation impact CAPR's short‑term stock price volatility and liquidity, especially around upcoming corporate events or earnings releases?
Are there comparable biotech companies that have faced similar securities lawsuits, and what were the market outcomes for those firms?